Amunix
is a California-based biotechnology company that develops and markets T-cell and cytokine therapies for the treatment of cancer... Read moreAmunix
is a California-based biotechnology company that develops and markets T-cell and cytokine therapies for the treatment of cancer... Read more
News
Feb 09, 2022
PharmiWeb
Amunix: Sanofi completes acquisition of Amunix
Dec 23, 2021
Global Legal Chronicle
Amunix: Sanofi's Pending Acquisition of Amunix
Dec 21, 2021
BioSpace
Amunix: Sanofi Goes Big with $1 Billion Immuno-Oncology Buy
Dec 21, 2021
MedCity News
Amunix: Sanofi's $1B Amunix acquisition aims for targeted, safer T cell engagers for cancer
Dec 21, 2021
BioPharma Dive
Amunix: Sanofi to buy cancer immunotherapy biotech for $1B
Dec 21, 2021
PE Hub Network
Amunix: Sanofi to buy PE-backed Amunix Pharmaceuticals
Dec 21, 2021
Endpoints News
Amunix: Pouncing on next-gen I/O play, Sanofi acquires Amunix for $1B+ and picks up 'universal mask' tech
Dec 21, 2021
BioCentury
Amunix: Happy customer: Sanofi buying Amunix in $1B deal
Dec 21, 2021
The Business Journals
Amunix: Cancer drug maker lands $1.2 billion Big Pharma deal
Oct 07, 2021
GlobeNewswire
Press Release: Amunix : Amunix Presents Preclinical Data on Its XPAT T Cell Engager Platform at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics
Amunix Competitors
1
2
3
4
5
6
7
8
9
10